opensafely / antibody-and-antiviral-deployment

While vaccines remain the best strategy to prevent COVID-19, mAbs could potentially benefit certain vulnerable populations before or after exposure to SARS-CoV-2, such as the unvaccinated or recently vaccinated high-risk patients.
MIT License
1 stars 4 forks source link

Add Codespaces config #66

Closed lucyb closed 4 months ago

lucyb commented 4 months ago

This will provide a development environment for researchers containing:

This can be used in Codespaces or locally via devcontainers in VS Code.

It's based on the work being done for https://github.com/opensafely-core/codespaces-initiative/issues/43.